Tanbo T, Kjekshus E, Dale P O, Storeng R, Lunde O, Magnus O, Bjercke S, Abyholm T
Kvinneklinikken, Rikshospitalet, Oslo.
Tidsskr Nor Laegeforen. 1998 Feb 28;118(6):864-9.
The first results of intracytoplasmic sperm injection (ICSI) in Norway are presented. Acceptable fertilization rates were obtained for all indications; severe male infertility, as well as moderately reduced sperm quality where in vitro fertilization (IVF) and embryo transfer had previously failed. Furthermore, in cases where IVF had failed despite normal sperm quality, fertilization rates of 50-60% were achieved. The overall pregnancy rate was 24.9% per embryo transfer, and the live pregnancy rate per started cycle was 13.4%. As expected, the results improved with experience. The results were greatly influenced by the age of the female. In the age group 34 years or less, the total pregnancy rate per cycle was 32.4%, with a miscarriage rate of 24.2%. In the age group 35 years or more, (42% of the study group), the total pregnancy rate per embryo transfer was 15.2%, with a miscarriage rate of 75%. The corresponding implantation rates were 17.4% and 7.9% respectively. 23 children have been born so far, none with major malformations or chromosome abnormality symptoms.
本文展示了挪威胞浆内单精子注射(ICSI)的首批成果。所有适应症均获得了可接受的受精率;包括严重男性不育症,以及此前体外受精(IVF)和胚胎移植失败的精子质量中度下降的情况。此外,在精子质量正常但IVF仍失败的病例中,受精率达到了50 - 60%。每次胚胎移植的总体妊娠率为24.9%,每个启动周期的活产妊娠率为13.4%。不出所料,随着经验的积累结果有所改善。结果受女性年龄的影响很大。在34岁及以下年龄组,每个周期的总妊娠率为32.4%,流产率为24.2%。在35岁及以上年龄组(占研究组的42%),每次胚胎移植的总妊娠率为15.2%,流产率为75%。相应的着床率分别为17.4%和7.9%。到目前为止,已有23名儿童出生,无一有重大畸形或染色体异常症状。